Analyze Diet
Mediators of inflammation2021; 2021; 9501478; doi: 10.1155/2021/9501478

MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.

Abstract: The purpose of the study was to compare the results of sepsis scoring (clinical examination and clinical pathology) to the concentrations of matrix-metalloproteinases (MMPs) -2, -8, and -9; tissue-inhibitor of metalloproteinases (TIMPs) -1 and -2; and inflammatory chemokines interleukin (IL) 1β and tumor-necrosis-factor-alpha (TNF-α) in plasma and peritoneal fluid of equine colic patients. A modified sepsis scoring including general condition, heart and respiratory rate, rectal temperature, mucous membranes, white blood cell count (WBC), and ionized calcium was applied in 47 horses presented with clinical signs of colic. Using this scoring system, horses were classified as negative (n = 32, ≤6/19 points), questionable (n = 9, 7-9/19 points), or positive (n = 6, ≥10/19 points) for sepsis. MMPs, TIMPs, IL-1β, and TNF-α concentrations were evaluated in plasma and peritoneal fluid using species-specific sandwich ELISA kits. In a linear discriminant analysis, all parameters of sepsis scoring apart from calcium separated well between sepsis severity groups (P < 0.05). MMP-9 was the only biomarker of high diagnostic value, while all others remained insignificant. A significant influence of overall sepsis scoring on MMP-9 was found for peritoneal fluid (P = 0.005) with a regression coefficient of 0.092, while no association was found for plasma (P = 0.085). Using a MMP-9 concentration of >113 ng/ml in the peritoneal fluid was found to be the ideal cutoff to identify positive sepsis scoring (≥10/19 points; sensitivity of 83.3% and specificity of 82.9%). In conclusion, MMP-9 was found to be a biomarker of high diagnostic value for sepsis and endotoxemia in equine colic. The evaluation of peritoneal fluid seems preferable in comparison to plasma. As abdominocentesis is commonly performed in the diagnostic work-up of equine colic, a pen-side assay would be useful and easy-to-perform diagnostic support in the decision for therapeutic intervention.
Publication Date: 2021-01-05 PubMed ID: 33488296PubMed Central: PMC7803393DOI: 10.1155/2021/9501478Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates how measuring the concentration of matrix-metalloproteinases (MMPs) in peritoneal fluid can serve as a valuable biomarker for identifying sepsis and endotoxemia in horses exhibiting colic symptoms. Of all biomarkers studied, MMP-9 emerged as the most diagnostically significant.

Objective and Methodology of the Research

  • The researchers aimed to evaluate various biomarkers in relation to sepsis scoring, which is typically conducted through clinical examination and pathology.
  • The biomarkers studied included matrix-metalloproteinases (MMPs) -2, -8, and -9, tissue-inhibitor of metalloproteinases (TIMPs) -1 and -2, and inflammatory chemokines interleukin (IL) 1 and tumor-necrosis-factor-alpha (TNF-).
  • Samples for testing these indicators were drawn from both the plasma and the peritoneal fluid of 47 horses presented with clinical symptoms of colic.
  • A modified sepsis scoring approach was developed and applied, taking into account factors such as general condition, heart and respiratory rate, rectal temperature, mucous membranes, white blood cell count (WBC), and ionized calcium.
  • Based on the score, horses were categorized as negative, questionable, or positive for sepsis.

Key Findings

  • The research found that almost all the scoring parameters, except calcium, distinguished well between sepsis severity groups.
  • Among the various biomarkers tested, MMP-9 exhibited the highest diagnostic value. The other biomarkers did not show significant diagnostic utility.
  • There was a notable association between overall sepsis scoring and MMP-9 concentration in the peritoneal fluid, while the same was not found for plasma.
  • A concentration of over 113 ng/ml of MMP-9 in the peritoneal fluid was identified as the optimal cutoff to determine positive sepsis scoring.

Conclusion and Implications

  • MMP-9 concentration in peritoneal fluid was established as a highly potent marker for diagnosing sepsis and endotoxemia in horses suffering from colic.
  • This suggests that peritoneal fluid, compared to plasma, is a more reliable source for conducting such diagnostic tests.
  • The researchers propose that, as abdominocentesis (the collection of peritoneal fluid) is a regular procedure in diagnosing equine colic, a quick and easy-to-perform “pen-side” assay to measure MMP-9 could be a valuable tool for deciding on therapeutic interventions.

Cite This Article

APA
Barton AK, Richter IG, Ahrens T, Merle R, Alalwani A, Lilge S, Purschke K, Barnewitz D, Gehlen H. (2021). MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic. Mediators Inflamm, 2021, 9501478. https://doi.org/10.1155/2021/9501478

Publication

ISSN: 1466-1861
NlmUniqueID: 9209001
Country: United States
Language: English
Volume: 2021
Pages: 9501478

Researcher Affiliations

Barton, Ann Kristin
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.
Richter, Ina-Gabriele
  • Research Centre of Medical Technology and Biotechnology, Bad Langensalza, Germany.
Ahrens, Tanja
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.
Merle, Roswitha
  • Institute for Veterinary Epidemiology, Freie Universitaet Berlin, Berlin, Germany.
Alalwani, Abdollah
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.
Lilge, Svenja
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.
Purschke, Katrin
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.
Barnewitz, Dirk
  • Research Centre of Medical Technology and Biotechnology, Bad Langensalza, Germany.
Gehlen, Heidrun
  • Equine Clinic, Freie Universitaet Berlin, Berlin, Germany.

MeSH Terms

  • Animals
  • Ascitic Fluid / chemistry
  • Biomarkers / metabolism
  • Colic / metabolism
  • Endotoxemia / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Horses
  • Interleukin-1beta / metabolism
  • Leukocyte Count
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 8 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Sepsis / blood
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Tumor Necrosis Factor-alpha

Conflict of Interest Statement

The authors declare that none of them have conflicts of interest.

References

This article includes 65 references
  1. Werners AH, Bull S, Fink-Gremmels J. Endotoxaemia: a review with implications for the horse.. Equine Veterinary Journal 2005;37(4):371–383.
    doi: 10.2746/0425164054529418pubmed: 16028631google scholar: lookup
  2. Morris DD. Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis.. Journal of Veterinary Internal Medicine 1991;5(3):167–181.
  3. Pugin J, Widmer M-C, Kossodo S, Liang C-M, Preas HL, Suffredini AF. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators.. American Journal of Respiratory Cell and Molecular Biology 1999;20(3):458–464.
    doi: 10.1165/ajrcmb.20.3.3311pubmed: 10030844google scholar: lookup
  4. Ollivier FJ, Brooks DE, Van Setten GB. Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis.. Veterinary Ophthalmology 2004;7(6):397–405.
  5. Cena J, Lalu MM, Rosenfelt C, Schulz R. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide.. European Journal of Pharmacology 2008;582(1-3):116–122.
    doi: 10.1016/j.ejphar.2007.12.019pubmed: 18242597google scholar: lookup
  6. Benbarek H, Deby-Dupont G, Caudron I. Interactions between lipopolysaccharides and blood factors on the stimulation of equine polymorphonuclear neutrophils.. Veterinary Immunology and Immunopathology 1998;64(4):313–322.
    doi: 10.1016/S0165-2427(98)00142-1pubmed: 9764724google scholar: lookup
  7. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.. Journal of Clinical Investigation 1996;98(11):2572–2579.
    doi: 10.1172/JCI119076pmc: PMC507715pubmed: 8958220google scholar: lookup
  8. Paemen L, Jansen PM, Proost P. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia.. Cytokine 1997;9(6):412–415.
    doi: 10.1006/cyto.1996.0183pubmed: 9199875google scholar: lookup
  9. Clutterbuck AL, Harris P, Allaway D, Mobasheri A. Matrix metalloproteinases in inflammatory pathologies of the horse.. Veterinary Journal 2010;183(1):27–38.
    doi: 10.1016/j.tvjl.2008.09.022pubmed: 19022687google scholar: lookup
  10. Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease.. Cold Spring Harbor Perspectives in Biology 2011;3(12).
    doi: 10.1101/cshperspect.a005058pmc: PMC3225943pubmed: 21917992google scholar: lookup
  11. Tayebjee MH, Lip GYH. Matrix metalloproteinases and the extracellular matrix.. .
  12. Lalu MM, Cena J, Chowdhury R, Lam A, Schulz R. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.. British Journal of Pharmacology 2006;149(1):31–42.
    doi: 10.1038/sj.bjp.0706823pmc: PMC1629401pubmed: 16880766google scholar: lookup
  13. Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages.. Journal of Immunology 1994;152:3637–3644.
    pubmed: 8144939
  14. Fugler LA, Eades SC, Moore RM, Koch CE, Keowen ML. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors.. American Journal of Veterinary Research 2013;74(3):473–480.
    doi: 10.2460/ajvr.74.3.473pubmed: 23438126google scholar: lookup
  15. Nakamura T, Ebihara I, Shimada N, Shoji H, Koide H. Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment.. The American Journal of the Medical Sciences 1998;316(6):355–360.
  16. Lorente L, Martín MM, Labarta L. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.. Critical Care 2009;13(5):p. R158.
    doi: 10.1186/cc8115pmc: PMC2784384pubmed: 19799791google scholar: lookup
  17. Lorente L, Martín MM, Solé-Violán J. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.. PLoS One 2014;9(4, article e94318).
  18. Lauhio A, Hästbacka J, Pettilä V. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines.. Pharmacological Research 2011;64(6):590–594.
    doi: 10.1016/j.phrs.2011.06.019pubmed: 21742038google scholar: lookup
  19. Serrano-Gomez S, Burgos-Angulo G, Niño-Vargas DC. Predictive value of matrix metalloproteinases and their inhibitors for mortality in septic patients: a cohort study.. Journal of Intensive Care Medicine 2017;1:p. 885066617732284.
    pubmed: 28931365
  20. Alqahtani MF, Smith CM, Weiss SL, Dawson S, Ralay Ranaivo H, Wainwright MS. Evaluation of new diagnostic biomarkers in pediatric sepsis: matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, mid-regional pro-atrial natriuretic peptide, and adipocyte fatty-acid binding protein.. PLoS One 2016;11(4, article e0153645).
  21. Maitra SR, Jacob A, Zhou M, Wang P. Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis.. International Journal of Clinical and Experimental Medicine 2010;3(3):180–185.
    pmc: PMC2929943pubmed: 20827315
  22. Bojic S, Kotur-Stevuljevic J, Aleksic A, Gacic J, Memon L, Simic-Ogrizovic S. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis after major abdominal surgery.. Disease Markers 2018;2018.
    pmc: PMC5976929pubmed: 29861795
  23. Bojic S, Kotur-Stevuljevic J, Kalezic N. Diagnostic value of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis-associated acute kidney injury.. The Tohoku Journal of Experimental Medicine 2015;237(2):103–109.
    doi: 10.1620/tjem.237.103pubmed: 26399271google scholar: lookup
  24. Hästbacka J, Linko R, Tervahartiala T. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality.. Anesthesia and Analgesia 2014;118(4):790–798.
    doi: 10.1213/ANE.0000000000000120pubmed: 24651234google scholar: lookup
  25. Becker S, Korpelainen S, Arvonen M. MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia.. Leukemia & Lymphoma 2019;24:1–8.
    pubmed: 31122146
  26. Hästbacka J, Fredén F, Hult M. Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.. PLoS One 2015;10(5, article e0125918).
  27. Sivula M, Hästbacka J, Kuitunen A. Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.. Acta Anaesthesiologica Scandinavica 2015;59(2):176–184.
    doi: 10.1111/aas.12423pubmed: 25329743google scholar: lookup
  28. Barton A, Shety T, Bondzio A, Einspanier R, Gehlen H. Metalloproteinases and their tissue inhibitors in comparison between different chronic pneumopathies in the horse.. Mediators of Inflammation 2015.
    doi: 10.1155/2015/569512pmc: PMC4681803pubmed: 26770019google scholar: lookup
  29. Barton A, Shety T, Bondzio A, Einspanier R, Gehlen H. Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction.. BMC Veterinary Research 2016;12(1):p. 282.
    doi: 10.1186/s12917-016-0915-1pmc: PMC5148864pubmed: 27938355google scholar: lookup
  30. Arosalo BM, Raekallio M, Rajamäki M. Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.. Acta Veterinaria Scandinavica 2007;49(1):p. 4.
    doi: 10.1186/1751-0147-49-4pmc: PMC1784101pubmed: 17244354google scholar: lookup
  31. Fietz S, Einspanier R, Hoppner S, Hertsch B, Bondzio A. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.. Equine Veterinary Journal 2008;40(3):266–271.
    doi: 10.2746/042516408X251921pubmed: 18089467google scholar: lookup
  32. Marttinen PH, Raulo SM, Suominen MM, Tulamo R-M. Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac.. Journal of Veterinary Medicine Series A 2006;53(6):311–318.
  33. Ghasemi SK, Mirshokraei P, Hassanpour H. In vitro study of matrix metalloproteinases 1, 2, 9, 13 and serum amyloid a mRNAs expression in equine fibroblast-like synoviocytes treated with doxycycline.. Canadian Journal of Veterinary Research 2018;82(2):82–88.
    pmc: PMC5914083pubmed: 29755186
  34. Pollitt CC, Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining.. Equine Veterinary Journal. Supplement 1998;26:139–144.
    pubmed: 9932105
  35. Loftus JP, Belnap JK, Black SJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance.. Veterinary Immunology and Immunopathology 2006;113(3-4):267–276.
    doi: 10.1016/j.vetimm.2006.05.010pubmed: 16822550google scholar: lookup
  36. Loftus JP, Johnson PJ, Belknap JK, Pettigrew A, Black SJ. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis.. Veterinary Immunology and Immunopathology 2009;129(3-4):221–230.
    doi: 10.1016/j.vetimm.2008.11.003pubmed: 19101039google scholar: lookup
  37. De Laat MA, Kyaw-Tanner MT, Nourian AR, McGowan CM, Sillence MN, Pollit CC. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.. Veterinary Immunology and Immunopathology 2011;140(3-4):275–281.
    doi: 10.1016/j.vetimm.2011.01.013pubmed: 21333362google scholar: lookup
  38. Sessions DR, Vick MM, Fitzgerald BP. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.. Journal of Animal Science 2009;87(12):3955–3966.
    doi: 10.2527/jas.2009-2088pubmed: 19684269google scholar: lookup
  39. Oddsdóttir C, Riley SC, Leask R. Dynamics of activities of matrix-metalloproteinases-9 and -2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare.. Theriogenology 2011;75(6):1130–1138.
  40. Rapacz-Leonard A, Kankofer M, Leonard M. Differences in extracellular matrix remodeling in the placenta of mares that retain fetal membranes and mares that deliver fetal membranes physiologically.. Placenta 2015;36(10):1167–1177.
  41. Yuan ZQ, Gobeil PAM, Saveria Campo M, Nasir L. Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive.. Virology 2010;396(1):143–151.
    doi: 10.1016/j.virol.2009.10.010pubmed: 19896685google scholar: lookup
  42. Mosseri S, Hetzel U, Hahn S. Equine sarcoid: in situ demonstration of matrix metalloproteinase expression.. Veterinary Journal 2014;202(2):279–285.
    doi: 10.1016/j.tvjl.2014.07.026pmc: PMC7128672pubmed: 25439440google scholar: lookup
  43. Strubbe DT, Brooks DE, Schultz GS. Evaluation of tear film proteinases in horses with ulcerative keratitis.. Veterinary Ophthalmology 2000;3(2-3):111–119.
  44. Boveland SD, Moore PA, Mysore J. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.. Veterinary Ophthalmology 2010;13(2):81–90.
  45. Matthews S, Dart AJ, Reid SW, Dowling BA, Hodgson DR. Predictive values, sensitivity and specificity of abdominal fluid variables in determining the need for surgery in horses with an acute abdominal crisis.. Australian Veterinary Journal 2002;80(3):132–136.
  46. Barton MH, Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease.. Journal of Veterinary Internal Medicine 1999;13(5):457–464.
  47. Saulez MN, Cebra CK, Tornquist SJ. The diagnostic and prognostic value of alkaline phosphatase activity in serum and peritoneal fluid from horses with acute colic.. Journal of Veterinary Internal Medicine 2004;18(4):564–567.
  48. Kilcoyne I, Nieto JE, Dechant JE. Predictive value of plasma and peritoneal creatine kinase in horses with strangulating intestinal lesions.. Veterinary Surgery 2019;48(2):152–158.
    doi: 10.1111/vsu.13147pubmed: 30588637google scholar: lookup
  49. Latson KM, Nieto JE, Beldomenico PM, Snyder JR. Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic.. Equine Veterinary Journal 2005;37(4):342–346.
    doi: 10.2746/0425164054529319pubmed: 16028624google scholar: lookup
  50. Yamout SZ, Nieto JE, Beldomenico PM, Dechant JE, le Jeune S, Snyder JR. Peritoneal and plasma D-lactate concentrations in horses with colic.. Veterinary Surgery 2011;40:817–824.
    pubmed: 21815898
  51. Peloso JG, Cohen ND. Use of serial measurements of peritoneal fluid lactate concentration to identify strangulating intestinal lesions in referred horses with signs of colic.. Journal of the American Veterinary Medical Association 2012;240(10):1208–1217.
    doi: 10.2460/javma.240.10.1208pubmed: 22559111google scholar: lookup
  52. Tennent-Brown BS. Interpreting lactate measurement in critically ill horses: diagnosis, treatment, and prognosis.. Compendium on Continuing Education for the Practicing Veterinarian 2012;34, article E2.
    pubmed: 22271469
  53. Arden WA, Stick JA. Serum and peritoneal fluid phosphate concentrations as predictors of major intestinal injury associated with equine colic.. Journal of the American Veterinary Medical Association 1988;193(8):927–931.
    pubmed: 3192473
  54. Rieger M, Kochleus C, Teschner D. A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses.. Analytical and Bioanalytical Chemistry 2014;406(22):5507–5512.
    doi: 10.1007/s00216-014-7944-zpubmed: 24928115google scholar: lookup
  55. Kilcoyne I, Nieto JE, Dechant JE. Diagnostic value of plasma and peritoneal fluid procalcitonin concentrations in horses with strangulating intestinal lesions.. Journal of the American Veterinary Medical Association 2020;256(8):927–933.
    doi: 10.2460/javma.256.8.927pubmed: 32223710google scholar: lookup
  56. Breuer J, Schusser GF. Establishing a sepsis-score for adult equine patients.. Pferdeheilkunde 2012;28(4):421–428.
    doi: 10.21836/PEM20120406google scholar: lookup
  57. Delesalle C, Dewulf J, Lefebvre RA. Determination of lactate concentrations in blood plasma and peritoneal fluid in horses with colic by an Accusport analyzer.. Journal of Veterinary Internal Medicine 2007;21(2):293–301.
  58. Cesarini C, Monreal L, Armengou L, Delgado MÁ, Ríos J, Jose-Cunilleras E. Progression of plasma D-dimer concentration and coagulopathies during hospitalization in horses with colic.. Journal of Veterinary Emergency and Critical Care 2014;24(6):672–680.
    doi: 10.1111/vec.12211pubmed: 25123566google scholar: lookup
  59. Monreal L, Cesarini C. Coagulopathies in horses with colic.. The Veterinary Clinics of North America. Equine Practice 2009;25(2):247–258.
    doi: 10.1016/j.cveq.2009.04.001pubmed: 19580937google scholar: lookup
  60. Delgado MA, Monreal L, Armengou L, Ríos J, Segura D. Peritoneal D-dimer concentration for assessing peritoneal fibrinolytic activity in horses with colic.. Journal of Veterinary Internal Medicine 2009;23(4):882–889.
  61. Monreal L, Anglés A, Espada Y, Monasterio J, Monreal M. Hypercoagulation and hypofibrinolysis in horses with colic and DIC.. Equine Veterinary Journal. Supplement 2000;32(S32):19–25.
  62. Vanlaere I, Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.. Clinical Microbiology Reviews 2009;22(2):224–239.
    doi: 10.1128/CMR.00047-08pmc: PMC2668236pubmed: 19366913google scholar: lookup
  63. Yassen KA, Galley HF, Webster NR. Matrix metalloproteinase-9 concentrations in critically ill patients.. Anaesthesia 2001;56(8):729–732.
  64. Xu C, Xu J, Lu L, Tian W, Ma J, Wu M. Identification of key genes and novel immune infiltration-associated biomarkers of sepsis.. Innate Immunity 2020;26(8):666–682.
    doi: 10.1177/1753425920966380pmc: PMC7787554pubmed: 33100122google scholar: lookup
  65. Guo W, Gao X, Zhan R, Zhao Z, Xu K, Tang B. Tricolor imaging of MMPs to investigate the promoting roles of inflammation on invasion and migration of tumor cells.. Talanta 2021;222:p. 121525.
    doi: 10.1016/j.talanta.2020.121525pubmed: 33167235google scholar: lookup